Category Archives: Medicine Wellness Health

Medicine Wellness Health

Made in Taiwan: improved medical outcomes – MEDICA 2018

The Taiwan External Trade Development Council – TAITRA – presents an elite group of 15 companies at this year’s MEDICA.

Made in Taiwan: improved medical outcomes - MEDICA 2018

Taiwan is a country founded on technology and the relentless drive for innovation. It benefits from the ambitions of its individual researchers, their institutes and companies and from the engagement and support from the Taiwan External Trade Development Council – TAITRA. At this year“s MEDICA, TAITRA presents an elite group of 15 companies – the recipients of TAITRA’s Taiwan Excellence awards – displaying technology to improve efficiency, process and, ultimately, outcomes to the world“s doctors, caregivers, and patients.

The world’s population is aging and becoming more connected. This fact is of utmost importance to Taiwan; its commercial sectors are focused on issues associated with a citizenry maturing in-step with the West. Rehabotics Medical Technology Corporation has just brought an exceptional aid to the market, MirrorHand, which enables robot-assisted rehabilitation of the hands after a stroke. Weighing only 750 grams, it is by far the lightest robotic rehabilitation device for the hand. The mirrored motion transferred from healthy to compromised hand and the programmable passive motion rehabilitation functions support neuromuscular regeneration.

Some unique technologies are just as beneficial at either end of life. The Opro9 Smart Diaper from Civicloud is an example. By offering a diaper with networked moisture monitoring, this technology is an excellent low-cost, multifunctional device. Whether in a NICs unit where renal function monitoring is a key aspect to positive outcomes, to an assisted living center where the care must remain efficient but responsive and flexible, this simple system can alert staff to needs of each patient and ensure an exceptional quality of care while offering valuable data-points into the EHR.

The ability for doctors to reach rapid, accurate conclusions is key to diagnosis and continued evaluation. Leltek Inc. offers this through a best-in-class cordless ultrasound subsystem. Of particular interest is their system’s bring-your-own-device compatibility, its ultra-light design at only 330 grams, and the exceptional battery life of three hours – overcoming the issues associated with previous cordless ultrasound solutions.

Another company featured through Taiwan Excellence, AmCad, leverages existing ultrasound diagnostic equipment to achieve the most cost-effective sleep apnea (OSA) diagnosis. As the understanding of the denigrating effects this condition plays in the general population becomes established, AmCad’s UO system delivers standardized ultrasound-head positioning and output data analysis to achieve an accurate diagnosis within 10 minutes on a fully awake patient, thereby eliminating the need for expensive overnight evaluation.

These Taiwan Excellence recipients and others organized by TAITRA will be presented during the MEDICA in Dusseldorf, Germany, from November 12th through the 15th in hall 17 Stand A61. All are interested in realizing opportunities for technological cooperation and business development with the global medical community. Hosts are on-hand and individual tours are available to meet your goals.

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,300 trained specialists stationed throughout its Taipei headquarters, four local branch offices in Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

Company-Contact
Taiwan External Trade Development Council
Frances Lin
Immermannstr. 33
40210 Dusseldorf
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pk/

Press
DRILLING GmbH
Ben Giese
CelsiusStr. 43
53125 Bonn
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pc/

Medicine Wellness Health

Uwe Diegel joins healthbank

Health database platform healthbank with new product manager – Diegel has been at the forefront of international changes in healthcare technology for the last 30 years

Uwe Diegel joins healthbank

Uwe Diegel

healthbank, the innovative platform for health data management in Switzerland, is happy to announce the arrival of Uwe Diegel in the role of Head Product Management product manager. Uwe Diegel was a concert pianist until the age of 26 and, following an accident that partially restricted movement in right arm, started a new career in medical diagnostics, quickly developing a particular interest in chronic diseases such as hypertension, asthma and diabetes. His intense scientific curiosity has led him not only to develop new technologies in these fields, but also to interest himself to field of medical manufacturing, industrial design and artificial intelligence.

Uwe is today considered to be a foremost expert in the field of blood pressure management, diabetes, asthma and in the manufacturing of medical diagnostics devices. In 2009, Uwe got interested in connected health as a means of providing better patient management and became involved in iHealth, the world leader in the field of connected health. Uwe served as CEO of iHealthLabs Europe until 2016. He left iHealth in 2016 to focus on health data management research.
Uwe Diegel has been at the forefront of international changes in healthcare technology for the last 30 years. His drive and passion for innovative technology have driven major changes in perception about healthcare. He has driven the manufacturing of medical devices to new horizons by forcing new practices in manufacturing and innovation. An internationally recognized expert in the management of cardiovascular disease and diabetes, he is continuously looking for better solutions to improve outcomes for patients. He has for the last few years spearheaded the dissemination and acceptance of connected health as a tool for providing better solutions for patients.
According to Uwe Diegel, „the creation of a new model of health and healthcare is the greatest single business opportunity of our lifetimes, and it will be accompanied by profound and lasting cultural change. Connection is everywhere and anything that can be connected will be connected. Connection is simply a natural evolution of technology. Every day, an average human being generates 500 megabytes of data, and now, most of this data is wasted. With healthbank, we expect to turn this data into something tremendously valuable financially, but more importantly tremendously valuable for medical research. Healthcare management is not the future of medicine, but its actual present. Tomorrow“s healthcare systems will consist of solutions, not for everyone, but indeed for every single one of us. And this is what we want to do with healthbank“.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables peo-ple to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, research-ers and organisations with large amounts of data to network with each other. Thus, the value of health and medical data can be optimally tapped on this independent, global health platform. healthbank promotes innovations in health care, from prevention to cure, at a more reasonable price and of better quality, for the benefit of individuals and society.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Freescan: the AI-based solution for stroke prevention (Source: © Maisense)

Hsinchu, Taiwan Oct 9th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention. The company now introduces an AI-based solution that can screen stroke through early detection of atrial fibrillation (AFib) which will also be presented at MEDICA 2018 November 12-15 in Düsseldorf, Germany at booth B26/Hall 11 and is a finalist for the MEDICA App COMPETITION.

Every four minutes, someone dies of stroke. Stroke is also a leading cause of long-term disability. Stroke is even called the „silent killer“ because it often come without any warning signs. However, up to 80% of stroke could be preventable by monitoring the major risk factors of stroke at an early stage.

13% of strokes are classified as hemorrhagic stroke. When the arteries of the brain weaken or break, allowing for blood to spread in the brain tissues, hemorrhagic strokes occur. They are most often caused by chronically hypertension. Up to 87% of strokes are classified as ischemic. An ischemic stroke occurs when a clot or a mass blocks a blood vessel, cutting off blood flow to a part of the brain. There are two main risk factors of ischemic strokes: arterial stiffness and atrial fibrillation (AFib).

A research, „Changes in arterial stiffness independently predict stroke in patients with essential hypertension,“ published in 2018 European Society of Cardiology (ESC), shows a demonstrated association and prediction between arterial stiffness and stroke for essential hypertension patients. The Framingham Heart Study (FHS) identified common factors and characteristics contributed to cardiovascular disease. Low-density lipoprotein (LDL), also called the „bad cholesterol“, is a notable enemy of arterial elasticity and fosters arterial stiffness. High LDL level raises the chances of a heart attack because it deposits in the walls of blood vessels that narrows the arteries or even clog. Other risk factors such as age, hypertension, smoking and diabetes are highly related to cardiovascular diseases.

It’s worth noting that patients with AFib have a five-fold increase in risk of stroke compared to those without. It affects 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. The European Heart Rhythm Association (EHRA), who published the aforementioned numbers, released a classification system of AFib-related symptoms in 2014. EHRA also stressed the fatal consequence even if AFib symptoms are not noticeable to patient or they may not feel uncomfortable. „Since an AFib episode can come and go, there may be many patients undetected and therefore they didn“t receive timely treatment. That“s why we take AFib screening seriously as a key measurement for stroke prevention,“ said Benjamin Chiu, CEO of Maisense.

AFib is usually diagnosed on an ECG but if a patient“s symptoms don“t occur while he sees his doctor or if they are back to normal at this point of time, the doctor would not be able to give advice properly. As a result, Maisense presented the Freescan device and the myFreescan App, which deliver an all-in-1 solution, utilizing artificial intelligence (AI) for early AFib detection, arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device. Users adopting Maisense’s solution can assess their risk level of strokes anytime.

From the patient“s perspective, the solution makes it very easy to measure and record all these biomedical signals at any time. Patients can monitor their own health conditions and take action at an early stage. Through the web-based Patient Care System, doctor can also be informed immediately when abnormal incidents occur – if a patient activated this function under doctor-patient privilege. It also provides sufficient data for doctors to make assessment quickly. The option does not only help to avoid unnecessary healthcare spending and time investments but also improves the service efficiency.

As Apple announced its Watch Series 4, which can record ECG and has received FDA approval, it is believed that more and more people are noticing the importance of irregular heart rhythm detection. Maisense is the world“s first company to provide an all-in-1 solution to screen the top 3 causes of stroke: arterial stiffness, hypertension, and atrial fibrillation in one single device. Maisense“s Freescan has received EU CE medical certification and is now available in Germany. Maisense will also present the solution at the upcoming „MEDICA 2018“ trade fair on November 12-15 in Düsseldorf, Germany, in Hall 11/ booth B26. Freescan has been selected as one of the 10 finalists in the MEDICA App COMPETITION ( https://www.medica-tradefair.com/cgi-bin/md_medica/lib/pub/tt.cgi/MEDICA_App_COMPETITION.html?oid=46182&lang=2&ticket=g_u_e_s_t). The top ten solutions will be presented at the MEDICA Connected Healthcare Forum, Hall 15C24 on Nov. 14 from 3pm.

For more information on pricing and the availability of Freescan, please visit Mindtec: https://www.mindtecstore.com/Maisense-Freescan-Cardiovascular-Monitor
and ME Health CHECK: https://www.mehealthcheck.de/maisense-freescan-bestellen/16/freescan-ihr-persoenliches-blutdruckmessgeraet-zur-herz-kreislauf-kontrolle?c=16

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

Capnography Equipment Market Size 366.5 Million by 2023 to Reach 4.3% CAGR

The global capnography equipment market to dominate by APAC while the overall market is to reach 4.3% CAGR to hit 366.5 million during 2016-2023 driven by accessories segment.

Capnography Equipment Market Size 366.5 Million by 2023 to Reach 4.3% CAGR

Watchers of Markets BV Logo

The global capnography equipment market is projected to reach USD 366.5 million by 2023 from USD 297.1 million in 2018, at a CAGR of 4.3%. Factors such as the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, increasing number of surgeries, and the evolving guidelines related to the clinical use of capnography are expected to drive the demand for capnography equipment in the coming years. However, the limited awareness about capnography and the shortage of skilled professionals to operate capnometers are the key challenges in this market.

Request a Sample PDF Copy of This Research Report: https://bit.ly/2NJOs5T

Based on product, the market is segmented into capnometers and accessories. The accessories segment is expected to account for the largest share of the capnography equipment market in 2018. The increasing adoption of capnography equipment during surgical procedures and post-operative monitoring, recommendations by various associations worldwide for the use of capnography equipment during patient monitoring for anesthesia (to enhance patient safety), and the growing number of complex and critical surgical procedures worldwide are the major factors that are expected to drive the growth of the capnography accessories market.

Based on end user, the market is segmented into hospitals and ambulatory surgery centers & home care. In 2018, the hospitals segment is expected to account for a larger share of this market. Factors such as the evolving guidelines related to the use of capnography and the rising incidence of chronic disorders are expected to drive the demand for capnography equipment in hospitals in the coming years.

The capnography equipment market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific is estimated to be the fastest-growing regional segment in the capnography equipment market majorly due to the presence of a large target patient population in the region, coupled with the increasing adoption of patient monitoring devices, including capnography equipment, due to the decreasing product costs as a result of local manufacturing and the strengthening of the distribution networks of prominent manufacturers. The growing medical tourism in several APAC countries is also expected to support the growth of this regional market during the forecast period.

Some of the major players operating in the capnography equipment market are NIHON KOHDEN (Japan), Philips (Netherlands), Medtronic (Ireland), Smiths Group (UK), Masimo Corporation (US), Drägerwerk AG & Co. KGaA (Germany), Hill-Rom Holdings (US), Nonin Medical (US), Infinium Medical (US), Criticare Technologies (US), SCHILLER (Switzerland), Zoe Medical (US), Edan Instruments (China), and Burtons Medical Equipment (UK).

Read More for Table of Content / Contact Us for the Corporate Discount: https://bit.ly/2IlT2ky

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the market.

By Company Type: Tier I – 45%; Tier II – 34%; and Tier III – 21%

By Designation: C-level – 14%; Director-level – 10%; and Others – 76%

By Region: North America – 40%; Europe – 32%; APAC – 20%; and RoW – 8%

Related Report:

Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) – Global Forecast to 2023

The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2%. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market.

The structural heart devices market in the Asia Pacific is projected to register the highest CAGR during the forecast period while the replacement procedures segment is expected to register the highest CAGR during the forecast period.

The major players operating in the structural heart devices market are Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK).

Read More: https://bit.ly/2xFMc5y

About Us:

We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.

Our experienced market research consultants understand a client“s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.

Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.

Contact
Watchers of Markets BV
Vinay Kudale
Henriëtte van der Meydreef 144
2492 JG Den Haag
Phone: +31- 85 888 111 6
E-Mail: sales@watchersofmarkets.com
Url: https://watchersofmarkets.com/

Medicine Wellness Health

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Maisense Presented Telecardiology System That Can Measure Blood Pressure and Record ECG Simultaneously at ESC Munich

Bach Chen, Vice President of business development, Maisense (Source: © Maisense)

Hsinchu, Taiwan Aug 29th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention, today announced the telecardiology system using a portable device „Freescan“ that can measure blood pressure and record ECG simultaneously.

„For most telecardiology systems on the market, they either provide only ECG, or provide both blood pressure and ECG but retrieve them from two independent devices. The more devices there are, the less likely for patients to use all of them regularly.“ said Bach Chen, Vice President of business development, Maisense.

The purpose of Maisense“s telecardiology system is to simplify the measurement procedure for patients. Through the combination of three elements: the Freescan device, the myFreescan App, and the Patient Care web platform, patients can measure blood pressure and ECG with a single device. In addition, doctors are able to monitor patients“ health condition easily through the web-based Patient Care System. Maisense Freescan in combination with the myFreescan App delivers a combined all-in-1 solution utilizing artificial intelligence (AI) for early atrial fibrillation detection (AFib), arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device.

According to World Health Organization (WHO)“s report in May 2018, stroke incidents are globally the second most common cause of death after ischaemic heart disease. Of the 56.9 million deaths worldwide in 2016, almost 6 million died persons died of strokes, this is about 10% of all the accounted deaths. However, up to 80% of strokes may be preventable by monitoring the major risk factors: arterial stiffness, atrial fibrillation (AFib), and hypertension.

The adoption of Maisense“s telecardiology system will enable every user of the solution to assess their risk level of strokes anytime. Therefore then they can take preventive actions to minimize the risk.

Maisense held a session to elaborate telecardiology system at the ESC (European Society of Cardiology) congress in Munich on August 28th.
„I believe that solid researches lead to excellent innovation. Therefore, we continue to push the boundaries on digital health support, and on top of that, we value each opportunity to present our system at conferences or academia“, said Benjamin Chiu, CEO, Maisense.

Maisense is also growing its channel and is actively looking for distributors in the European Union. In Germany, Maisense is excited to have formed a partnership with the well renowned TITAN Commerce and appPeople. TITAN Commerce is a leading distributor for Bio-/Neurofeedback, sportswear technology and wearables based in Germany. appPeople provides worldwide progressive impulses in the field of telemedicine. Freescan is also available in Germany at Mindtec and ME Health CHECK.

Maisense is proud to be a member of the Global Research & Industry Alliance (GLORIA-Semicon) which focuses on future-oriented technology and builds a cooperation platform between universities and the industry. The organization stimulates innovation and introduces Taiwan startup companies to the global market.

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

One Swiss model for the world – healthbank expands into Germany

healthbank Deutschland GmbH founded in Berlin – Karsten Stampa becomes CEO – Philosophy and values of the cooperative are transported

One Swiss model for the world - healthbank expands into Germany

Karsten Stampa

healthbank cooperative is expanding and has founded the subsidiary healthbank Deutschland GmbH in Berlin. CEO of the new company is Karsten Stampa, who contin-ues to act as COO/CFO of the parent company healthbank in Baar. „We are convinced that the model of a new and independent health data platform is not only a model for Switzerland, but for the whole world,“ explains Stampa.

The Swiss health data platform „healthbank“ revolutionizes the way personal health data is stored, used, exchanged and passed on for fair rewards. To this end, healthbank operates the world’s most advanced health data platform, which allows users to securely store health data and share it with doctors, hospitals and research institutions by means of authorization.

For Karsten Stampa, the move to Berlin is a logical step in health-bank’s expansion strategy. „We are convinced that our model of a neutral and independent health data platform is not only a model for Switzerland but will prevail all over the world.

The goal of healthbank in the near future is to offer the possibility of being able to use personal health data everywhere and at any time: „So not only at home, but also for example on vacation in the Serengeti or when one is on the road professionally“, explains Stampa. The data would be urgently needed, especially at remote locations in the event of a medical emergency, would help to understand people’s medical history quickly and easily and thus improve the quality of care, no matter where in the world it takes place“.

In terms of internationalization, the branch in Germany is the logical step for healthbank, explains Stampa. „The reasons are clear. In Germany, the domestic market with around 80 million inhabit-ants is of course very interesting. Much more exciting, however, is the fact that many international healthcare providers are based there alongside highly exciting start-ups with excellent, innovative approaches in the field of digital health. For example, we have entered into a cooperation with Thryve, a company that develops and sells software as a service in the field of mobile health applications,“ adds Stampa. In addition to the development of the national telematics structure or the development of the electronic health card, Stampa explains that many other developments can currently be observed in Germany. The first frontrunner projects of German insurers such as the Techniker Krankenkasse, the patient file of the AOK Nord-Ost or the health app Vivy were observed. „We are convinced that healthbank, as a bridge builder between the partially isolated ap-proaches, can make a major contribution to the control of health data among users in Germany.

This expansion will later be extended to other countries around the world. „This will enable us to export our future model. The healthbank cooperative is located in Switzerland and enables users to share their data with other partners in a secure and data protection-compliant manner. healthbank combines data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. For various reasons (including legislation), local operating companies will also have to be operated in the respective countries. „This will enable us to transport the philosophy and values of the Swiss cooperative to these countries and allow the healthbank ecosystem to grow rapidly worldwide,“ explains Stampa.
healthbank in Germany will soon start as a sales and operations company where customer relation-ships with German health service providers are to be established and project partners found. The core will be the announcement of the healthbank idea in Germany and the establishment of fur-ther customer relationships. „Through our cooperation with a globally active German management consultancy, we ensure a high degree of visibility in Germany“.

Stampa sees the implementation of the healthbank expansion strategy as one of his core tasks. „I have many discussions with potential customers and appearances at events,“ he explains. At the same time, the marketing strategy will be developed and implemented. „The search for investors and securing financing is always one of the most important tasks in such a project and is at the top of his list, explains the former management consultant in the areas of strategy and regulation. Stampa has therefore also planned a first funding round for the coming months in order to be able to build up the Marketing and Business Development department. „It may also be necessary to operate your own data platform in Germany so that an IT department can be added,“ explains Stampa.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables people to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, researchers and organizations with large amounts of data to network with each other. This enables the value of health and medical data to be optimally exploited on this independent, global health platform. healthbank promotes innovations in the health care system, from prevention to cure, at a more reasonable price and of better quality – for the benefit of individuals and society. www.healthbank.coop

healthbank ist die weltweit erste bürgereigene, neutrale und unabhängige Gesundheitsdaten-Transaktionsplattform, die es Menschen ermöglicht ihre Daten auf sichere und datenschutzkonforme Art und Weise mit anderen Partnern zu teilen. healthbank verbindet Datenquellen aller Art aus dem gesamten Gesundheitsbereich und belohnt Teilnehmer, ihre Gesundheitsdaten für Forschungszwecke zu teilen. Mit Sitz in der Schweiz steht healthbank für schweizerische Neutralität, Vertrauen und Datenschutz und ermöglicht es den teilnehmenden Bürgern, Forschern und Organisationen mit grossen Datenmengen sich miteinander zu vernetzen. Damit kann der Wert von Gesundheits- und medizinischen Daten auf dieser unabhängigen, globalen Gesundheitsplattform optimal erschlossen werden. healthbank fördert Innovationen im Gesundheitswesen, von der Prävention bis zur Heilung, zu einem angemesseneren Preis und besserer Qualität – für das Wohl des Einzelnen und der Gesellschaft.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

Improving radiation protection

EANM join forces with scientific organisations to investigate the impact of medical radiation exposure on patients and medical staff

(Vienna, August 21, 2018) Nuclear medical techniques are essential in diagnosing a large number of diseases and in treating various kinds of cancer. Since nuclear medicine is based on the use of radioactively labelled substances patients are exposed to a certain amount of radiation. Although doses are low and have to be weighted against the high diagnostic and therapeutic benefit, the improvement of radiation protection is a main concern of the European Association of Nuclear Medicine (EANM). „Recently, EANM has joined forces with scientific organisations from related disciplines in order to specify risk estimations and promote cutting edge research which will serve as a basis for improving protective measures. Patients as well as staff are going to benefit considerably from these efforts“, says EANM expert Prof. Klaus Bacher.

Modern health care is hardly conceivable without nuclear medicine. Nuclear imaging comprises highly efficient diagnostic techniques that provide precise information on early stages of numerous conditions, ranging from narrowed arteries over the presence of tumours to the onset of dementia. This is most valuable information that doctors can draw upon to design individually tailored and timely therapies for their patients. Apart from these diagnostic aspects, nuclear medicine also provides targeted treatments for cancer patients where high local tumor doses can be achieved while minimizing the radiation burden affecting healthy tissue.
Joining forces for better data
For nuclear medical diagnosis as well as treatment the patient is injected with substances, for example glucose, that are radioactively labelled. Although the applied radiation doses are low there is an ongoing discussion among experts to which extent risks such as cancer induction can be excluded. Highly important as this matter is for both patients and staff clinically relevant studies based on sufficient and appropriate data are still rare. In order to fill this gap and thus provide the prerequisite for reliable risk estimations the European Alliance for Medical Radiation Protection Research (EURAMED) was founded ( www.eibir.org/scientific-activities/joint-initiatives/european-alliance-for-medical-radiation-protection-research-euramed/). The goal of the association is to promote and support research in order to clarify the various and complex medical radiation protection issues and to translate the results into clinical practice. Together with a number of other scientifically related organisations EANM is a founding member of EURAMED and will have a leading role in the oncoming years through presidential and vice-presidential positions. It is for the first time that different disciplines such as radiology, radiotherapy, medical physics and nuclear medicine join forces in such a manner. A common strategic research agenda (SRA) for medical radiation protection has already been published.
Recommendations are under way
Another important step forward towards an improvement of radiation protection is MEDIRAD (Implications of Medical Low Dose Radiation Exposure). This project has been established in order to investigate the impact of medical low-dose radiation exposure on patients and medical staff and to set up science-based policy recommendations for their effective protection. It was developed under the guidance and with significant input of EURAMED and EANM ( www.medirad-project.eu/). MEDIRAD“s research consortium, consisting of over 70 scientists from 33 organizations and 14 countries, received 10 million Euros in funding from the European Commission and started in June 2017. „The research will significantly improve our medical understanding and practice of radiation protection“, says Prof. Bacher. In the field of nuclear medicine research results are expected to optimize the radiation exposure during diagnostic PET/CT examinations and to improve the treatment of thyroid cancer patients using radioactive iodine therapy. Other fields of research concern radiation exposure in breast radiotherapy and the impact of nuclear medical procedures in cardiovascular diseases. „EANM has always taken radiation protection seriously and welcomes the close cooperation of clinicians and medical physicists. Discussing and investigating these issues in a number of interdisciplinary scientific committees will lead to appropriate recommendations for the justified use of nuclear medical procedures very soon“, says Prof. Bacher.
https://www.facebook.com/officialEANM.
www.whatisnuclearmedicine.com
www.eanm.org

Presseagentur für Medizinthemen

Contact
impressum health & science communication
Frank von Spee
Hohe Brücke 1
20459 Hamburg
Phone: 040 31786410
E-Mail: vonspee@impressum.de
Url: http://www.impressum.de

Medicine Wellness Health

Partnership between Thryve and healthbank – intelligent mHealth solution for the detection of health risks

Expansion of the healthbank ecosystem – fitness trackers become health assistants – health care is improved – from prevention and screening to intervention and therapy

Partnership between Thryve and healthbank - intelligent mHealth solution for the detection of health risks

Thryve: Friedrich Lämmel (l), Paul Burggraf (m) and John Trimpop (r)

healthbank enters into another important partnership and brings mobile health services to its platform. The cooperation with the Berlin-based company Thryve is another milestone in healthbanks ecosystem strategy. Thryve, whose spin-off roots lie at the Fraunhofer Institute for Computer Graphics, develops and licenses software as a service in the field of mobile health applications. Via a single interface, a so-called single API, data from over 200 different fitness trackers, smart watches and portable medical devices can be connected. The cooperation between healthbank and Thryve links the services of both companies and enables healthbank users to integrate their personal devices. At the same time, the Single API solution is also open to other network partners of healthbank.

Thryve is driving forward the individualisation of health care through the use of so-called wearables by patients. „Our software enables health services to access health data from smartphones, smart watches, fitness trackers and other smart devices such as scales or blood pressure monitors via a single API,“ explains Thryve co-founder Paul Burggraf. „By enabling health services to understand and use the wealth of automatically generated data, we can fundamentally improve all aspects of health care – from prevention and screening to intervention and therapy,“ Burggraf adds.

How exactly does this work? „Health data from smart watches, fitness trackers or medical devices are easily integrated into digital health services and processed with Thryve – so that individual health status can easily be recognized, health risks automatically identified and the success of therapy measured in objective parameters. This helps us to assess and safeguard the activities, fitness and health of a person,“ Burggraf explains. This health information is supplied via standard sensors of millions of devices in use today. „An adaptive, individual interpretation layer makes different model types of wearables comparable with each other and identifies additional irregularities in the recorded data,“ he explains further. Together with the Charité University Hospital Berlin, Thryve has been developing and testing intelligent solutions for the detection of health risks and disease indicators for several years. Thryve is based on more than ten years of Fraunhofer research and combines artificial intelligence, professional software development and validated medical procedures.

For Reto Schegg, CEO of healthbank, Thryve is a dream partner. „The Healthbank platform is optimally designed to integrate partners and applications from the healthcare sector into healthbank’s ecosystem quickly, efficiently and highly securely. healthbank not only offers its partners a state-of-the-art architecture and security approach. The additional integration of wearables together with Thryve increases the attractiveness of the platform enormously.

This cooperation enables healthbank users to use individual tracking data from wearables in a standardised way and store it securely in their healthbank account in order to document, for example, successful rehabilitation or long-term observations. In addition, the release of the data for general practitioner, caregiver or within the family is guaranteed. „We believe in a future in which everyone has their own health in their own hands,“ says Burggraf. „A future in which personal assistants protect us from illness, automatically recognise illnesses and health risks and enable everyone to receive exactly the right treatment,“ Burggraf explains his vision. „A vision that we support as a safe, neutral and independent partner,“ explains Schegg from healthbank.

About Thryve:
mHealth Pioneers powers the individualization of health care. Our software enables health services to access sensible health data from smartphones, smartwatches, fitness trackers and the like through a single API. Since founding our company 2016 in Berlin, we have added corporates, fellow startups, care organizations and research institutions to our customers and support diverse indications such as oncology, affective disorders or cardiology. By enabling health services to understand and use automatically generated data, we create a holistic health picture and fundamentally improve care delivery – from prevention and screening to intervention and therapy.

Press contact Thryve
mHealth Pioniers GmbH
Paul Burggraf
Bismarckstrasse 10-12
D- 10625 Berlin
Tel. +49 152 531 617 34
paul.burggraf@thryve.de

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables people to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, researchers and organisations with large amounts of data to network with each other. Thus, the value of health and medical data can be optimally tapped on this independent, global health platform. healthbank promotes innovations in health care, from prevention to cure, at a more reasonable price and of better quality, for the benefit of individuals and society.
www.healthbank.coop

Press contact healthbank
healthbank innovation AG
Pauline Geniets
Blegistrasse 17a, CH-6340 Baar
Tel. +41 (0) 41 552 24 00
press@healthbank.coop

healthbank ist die weltweit erste bürgereigene, neutrale und unabhängige Gesundheitsdaten-Transaktionsplattform, die es Menschen ermöglicht ihre Daten auf sichere und datenschutzkonforme Art und Weise mit anderen Partnern zu teilen. healthbank verbindet Datenquellen aller Art aus dem gesamten Gesundheitsbereich und belohnt Teilnehmer, ihre Gesundheitsdaten für Forschungszwecke zu teilen. Mit Sitz in der Schweiz steht healthbank für schweizerische Neutralität, Vertrauen und Datenschutz und ermöglicht es den teilnehmenden Bürgern, Forschern und Organisationen mit grossen Datenmengen sich miteinander zu vernetzen. Damit kann der Wert von Gesundheits- und medizinischen Daten auf dieser unabhängigen, globalen Gesundheitsplattform optimal erschlossen werden. healthbank fördert Innovationen im Gesundheitswesen, von der Prävention bis zur Heilung, zu einem angemesseneren Preis und besserer Qualität – für das Wohl des Einzelnen und der Gesellschaft.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

2nd International Conference on Diabetes, Nutrition, Metabolism & Medicare

– November 05-06, 2018 | Philadelphia, USA

2nd International Conference on Diabetes, Nutrition, Metabolism & Medicare

Diabetes| Nutrition| Metabolism | Medicare- Join Hands to Eradicate the Diabetes
– November 05-06, 2018 | Philadelphia, USA
The significant progress Diabetes sector is hampered by patenting; Diabetic medicines will most likely always remain a niche market. Diabetes is one of the most challenging diseases throughout the world. The impact of diabetes on the individual quality of life and the general economy in Italy is substantial. There are a number of different types of diabetes drugs – with some having similar ways of acting. The 50+ diabetes drugs available in the world in the form of tablets or injection suspension and placed into different drug“s classes. A large number of innovations are therefore lost.
The Global Market for Diabetes Management accounted for 40 billion USD in 2010 and is anticipated to attain a market size of around 114 billion USD following a growth rate of 13.5% CAGR. The foremost products in this market consist of glucose meters, testing strips, lancets, continuous blood glucose meters, syringes, insulin pumps, insulin & its devices such as patches and anti-diabetic drugs. However, hypoglycaemic agent, test strips, and anti-diabetic drugs are the most revenue generating products.
While diabetes usually cannot be cured, drug manufacturers and biotech companies make glucose monitors, and drug products to assist to manage the condition. It’s calculable that entire market for diabetes products and related care is worth $92 billion in the U.S. The conventional therapeutic information is thought to be inside each one’s scope and does not require any review or preparing to practice it.
According to the (CMS) Centres for Medicare and Healthcare, 32nd of Medicare outlay is attributed to the diabetes population. Medicare has expanded medical coverage of monitoring devices, screening tests and visits, academic efforts, and preventive medical services for its diabetic enrolees. However, oral anti diabetic drugs and hypoglycaemic agents were excluded from reimbursement.
„2nd International Conference on Diabetes, Nutrition, Metabolism & Medicare“, going to be held during November 5-6, 2018 in Philadelphia, USA is going to be the biggest conference dedicated to Diabetes and its consequences day to day. It provides a premier technical forum for reporting and learning about the latest research and development, along with discussing new applications and technologies related to Diabetes, Nutrition, Metabolism & Medicare. Events include hot topics presentations from all over the world and professional networking with industries, leading working groups and panels. Diabetes Conference 2018 will be organized around the theme- „Join Hands to Eradicate the Diabetes“

Allied Academies is an established and reputed publisher which started publishing in the year 1994. Initially the focus of the group was to organize conferences and publish articles in the realm of Business and Management, with time the publisher expanded the subject scope and presently focusing on other subject areas.

Contact
Allied Academics
Karleen Gloria
85 Great Portland St pa
W1W 7LT Marylebone, London
Phone: +448000868979
E-Mail: diabetes@alliedscholars.net
Url: http://diabetesconference.alliedacademies.com/

Medicine Wellness Health

Dr. Hüseyin Sahinbas: New President of German Hyperthermia Society

Shanghai 2018 – Successful DGHT-eV expansion in China

Dr. Hüseyin Sahinbas: New President of German Hyperthermia Society

Dr. Sahibas present DGHT-eV

With Dr. Hüseyin Sahinbas, whose areas of specialty include hyperthermia, the German Hyperthermia Society, or DGHT-eV for short ( www.dght-ev.de), has elected a new president with particularly ambitious goals. One of his first actions in office involved setting up an academic exchange with colleagues in China and entering into a cooperation agreement with Shanghai“s Shulan Hospital. Both parties expect a creative and intensive clinical and scientific exchange in this context, in order to „further expand the quality and application of hyperthermia,“ according to Dr. Quing Xu, Director of the Tongji University Cancer Center. In addition to further scientific studies, this work will include defining and implementing guidelines for performing hyperthermia treatments with regard to individual entities. The objective of this step is to further establish the relevance of hyperthermia in conventional school medicine and to boost its acceptance. „We not only want to expand our international contacts, but also want to foster the cooperation of national associations,“ said Dr. Sahinbas, who outlined his goals as DGHT-eV President as follows:

– Build bridges between all associations dedicated to complementary (oncological) and conventional fields
– Build bridges between decision-makers in politics and medicine
– Build bridges between scientific research and colleagues working „in the trenches“
– Build bridges between doctors and affected patients seeking help
– Build bridges between science, patients and the media

„Hyperthermia is already supported by detailed studies in many areas and now has to make the leap to becoming accepted by insurance systems,“ says Dr. Sahinbas, adding, „This will be one of my core tasks as President. I will largely act as a link between many associations and colleagues, I see myself as a bridge builder for politics, science, but also for commercial institutions in medicine and insurance.“ True to his motto „It takes a vision to have a current plan,“ DGHT-eV will reposition itself within this framework to provide more active support for colleagues and to convince other physicians of the benefits of this therapy form. In order to achieve this in the near future, intensive talks are currently underway, for example at the Berlin Charite Hospital, to create a „hyperthermia specialist“ training course. „Clear guidelines and specialist training will make hyperthermia significantly more attractive for junior colleagues, and we hope to generate broad interest among young doctors. I particularly look forward to the task of communicating knowledge and experience in the treatment of cancer patients.
That makes my position as president of DGHT-eV very gratifying,“ says Dr. Sahinbas, whose long-term objectives include establishing an independent professorship for hyperthermia.

Dr. Hüseyin Sahinbas – President DGHT-eV

Bei Krebsleiden und chronischen Krankheiten ist die Hyperthermie mittlerweile mehr als nur ein Hoffnungsschimmer zur Prognoseverbesserung. Denn Hyperthermie kann Leben retten, verlängern und erheblich verbessern.

Das ist das Ziel der DGHT-eV

Company-Contact
DGHT-eV
Hüseyin Sahinbas
Gutenbergstr. 8
26135 Oldenburg
Phone: +49 441 – 936 54 58 – 6
E-Mail: info@dght-ev.de
Url: http://www.dght-ev.de

Press
DGHT-e.V.
Hüseyin Sahinbas
Gutenbergstr. 8
26135 Oldenburg
Phone: 0441 – 936 54 58 – 6
E-Mail: info@dght-ev.de
Url: https://www.dght-ev.de/home